{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:13:09Z","timestamp":1789557189658,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ahj.2023.04.010","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T21:05:05Z","timestamp":1682197505000},"page":"83-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial"],"prefix":"10.1016","volume":"262","author":[{"given":"Simon","family":"Parlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro Di","family":"Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Goodliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Motazedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Prosperi-Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baylie","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zandra","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa Fay","family":"Lepage-Ratte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Feagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwadwo","family":"Kyeremanteng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Marbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marino","family":"Labinaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie P.","family":"Belley-Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hibbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-7691","authenticated-orcid":false,"given":"Rebecca","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.04.010_bib0001","article-title":"Inotropes for cardiogenic shock - six of one, half a dozen of the other","volume":"41","author":"Mathew","year":"2022","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.ahj.2023.04.010_bib0002","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American heart association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ahj.2023.04.010_bib0003","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s12630-022-02337-7","article-title":"Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis","volume":"69","author":"Fernando","year":"2022","journal-title":"Can J Anaesth"},{"issue":"7","key":"10.1016\/j.ahj.2023.04.010_bib0004","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/jcm9072051","article-title":"Vasopressors and Inotropes in acute myocardial infarction related cardiogenic shock: a systematic review and meta-analysis","volume":"9","author":"Karami","year":"2020","journal-title":"J Clin Med"},{"issue":"3 Pt 2","key":"10.1016\/j.ahj.2023.04.010_bib0005","first-page":"III168","article-title":"Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure","volume":"73","author":"Monrad","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.04.010_bib0006","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1067\/mhj.2002.125620","article-title":"Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study","volume":"144","author":"Burger","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2023.04.010_bib0007","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.04.010_bib0008","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","article-title":"Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study","volume":"41","author":"Felker","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ahj.2023.04.010_bib0009","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.04.010_bib0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.04.010_bib0011","first-page":"29","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.04.010_bib0012","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.04.010_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023322","article-title":"Lactate clearance as a surrogate for mortality in cardiogenic shock: insights from the DOREMI trial","volume":"11","author":"Marbach","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2023.04.010_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacadv.2022.100034","article-title":"Optimal perfusion targets in cardiogenic shock","volume":"1","author":"Mathew","year":"2022","journal-title":"JACC Advances"},{"issue":"21","key":"10.1016\/j.ahj.2023.04.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021570","article-title":"Implications of myocardial infarction on management and outcome in cardiogenic shock","volume":"10","author":"Jung","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2023.04.010_bib0016","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jcin.2020.06.037","article-title":"Arterial lactate in cardiogenic shock: prognostic value of clearance versus single values","volume":"13","author":"Fuernau","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.04.010_bib0017","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.04.010_bib0018","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.04.010_bib0019","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.04.010_bib0020","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.297.15.joc70035","article-title":"Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial","volume":"297","author":"Alexander","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.04.010_bib0021","first-page":"183","volume":"9","author":"Zeymer","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.ahj.2023.04.010_bib0022","first-page":"419","article-title":"Inotrope and vasopressor use in cardiogenic shock: what, when and why?","volume":"28","author":"Hu","year":"2022","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.ahj.2023.04.010_bib0023","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.04.010_bib0024","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2023.04.010_bib0025","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/CCM.0b013e3181809846","article-title":"Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction","volume":"36","author":"Fuhrmann","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ahj.2023.04.010_bib0026","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.recesp.2017.12.020","article-title":"Vasoactive inotropic score as a predictor of mortality in adult patients with cardiogenic shock: medical therapy versus ECMO","volume":"72","author":"Na","year":"2019","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.ahj.2023.04.010_bib0027","first-page":"434","article-title":"Mechanical circulatory support in the treatment of cardiogenic shock","volume":"28","author":"Fernando","year":"2022","journal-title":"Curr Opin Crit Care"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:10:11Z","timestamp":1757571011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323000972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":27,"alternative-id":["S0002870323000972"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.04.010","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}